Innovation Leadership COVVI is a design-led medical device company with a recent Technology Innovator of the Year award and ongoing recognition as a “One to Watch” in 2026, signaling strong credibility for premium prosthetic and robotic hand solutions to potential partners and clinicians.

Product Expansion The launch of a multi-articulated hand in 2025 and shorter, lighter hand variants open opportunities to target diverse clinical needs, hospitals, and rehabilitation centers seeking advanced, ergonomic upper-limb solutions for different user populations.

Global Outreach Active participation in international events such as OTWorld in Leipzig and multiple exhibitions positions COVVI for global partnerships, distributor networks, and clinical collaborations across continents.

Clinical Collaboration With a focus on clinicians and user-centered design, there is a strong case to engage healthcare systems, rehab clinics, and prosthetics centers for adoption pilots, training programs, and outcomes-based studies promoting real-world value.

Growth Readiness Revenue below one million and a lean team (11-50 employees) indicate agility for strategic partnerships, OEM/white-label opportunities, and collaboration with larger device manufacturers to scale deployment and market reach.